286 related articles for article (PubMed ID: 28629398)
21. [Diagnostic value of brain biopsy in intravascular large B-cell lymphoma mimicking progressive multifocal leukoencephalopathy: case report].
Takamine Y; Ikumi N; Onoe H; Hayase M; Nagasawa Y; Sakagami M; Sugiyama K; Nakagawa S; Uchino Y; Takahashi H; Hirabayashi Y; Nozaki T; Miura K; Inomata H; Iriyama N; Shiraiwa H; Kobayashi S; Kitamura N; Hatta Y; Matsukawa Y; Takei M
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(2):111-5. PubMed ID: 24835139
[TBL] [Abstract][Full Text] [Related]
22. Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring.
Hunt D; Giovannoni G
Pract Neurol; 2012 Feb; 12(1):25-35. PubMed ID: 22258169
[TBL] [Abstract][Full Text] [Related]
23. Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab.
Kleinschmidt-DeMasters BK; Miravalle A; Schowinsky J; Corboy J; Vollmer T
J Neuropathol Exp Neurol; 2012 Jul; 71(7):604-17. PubMed ID: 22710964
[TBL] [Abstract][Full Text] [Related]
24. [Atypical progressive multifocal leukoencephalopathy (PML) in a patient with pulmonary sarcoidosis].
Le Guilloux J; Roubiou C; Mallet J; Bouvry D; Alkhalil A; Coman I; Belin C; Gorochov G; Carpentier A; Mokhtari K; Carpentier AF
Rev Neurol (Paris); 2010 Mar; 166(3):341-5. PubMed ID: 19589551
[TBL] [Abstract][Full Text] [Related]
25. Progressive multifocal leukoencephalopathy mimicking glioma in a patient with idiopathic CD4 lymphocytopenia.
Gupta HV; Gokden M; Ramakrishnaiah RH; Archer RL
Acta Neurol Belg; 2016 Sep; 116(3):391-4. PubMed ID: 26319126
[No Abstract] [Full Text] [Related]
26. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.
Van Assche G; Van Ranst M; Sciot R; Dubois B; Vermeire S; Noman M; Verbeeck J; Geboes K; Robberecht W; Rutgeerts P
N Engl J Med; 2005 Jul; 353(4):362-8. PubMed ID: 15947080
[TBL] [Abstract][Full Text] [Related]
27. Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
Fine AJ; Sorbello A; Kortepeter C; Scarazzini L
Ann Neurol; 2014 Jan; 75(1):108-15. PubMed ID: 24242357
[TBL] [Abstract][Full Text] [Related]
28. Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
Landy DC; Hecht EM
Clin Neuropharmacol; 2014; 37(2):45-51. PubMed ID: 24614671
[TBL] [Abstract][Full Text] [Related]
29. Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
Dong-Si T; Gheuens S; Gangadharan A; Wenten M; Philip J; McIninch J; Datta S; Richert N; Bozic C; Bloomgren G; Richman S; Weber T; Clifford DB
J Neurovirol; 2015 Dec; 21(6):637-44. PubMed ID: 25771865
[TBL] [Abstract][Full Text] [Related]
30. Adult anaplastic pilocytic astrocytoma - a diagnostic challenge? A case series and literature review.
Fiechter M; Hewer E; Knecht U; Wiest R; Beck J; Raabe A; Oertel MF
Clin Neurol Neurosurg; 2016 Aug; 147():98-104. PubMed ID: 27341279
[TBL] [Abstract][Full Text] [Related]
31. Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient.
Tortorella C; Direnzo V; D'Onghia M; Trojano M
Neurology; 2013 Oct; 81(16):1470-1. PubMed ID: 24127190
[No Abstract] [Full Text] [Related]
32. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
[TBL] [Abstract][Full Text] [Related]
33. Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
Berger JR; Neltner J; Smith C; Cambi F
Mult Scler Relat Disord; 2014 Nov; 3(6):728-31. PubMed ID: 25891552
[TBL] [Abstract][Full Text] [Related]
34. Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions.
Vola EA; Petracca M; Cocozza S; De Angelis M; Carotenuto A; Pontillo G; Morra VB; Tedeschi E; Lanzillo R
BMC Neurol; 2021 Apr; 21(1):146. PubMed ID: 33820529
[TBL] [Abstract][Full Text] [Related]
35. Early changes on electroencephalography in natalizumab-associated progressive multifocal leucoencephalopathy.
Kleiter I; Schröder M; Lürding R; Schuierer G; Clifford DB; Bogdahn U; Steinbrecher A; Pöschl P
Mult Scler; 2010 Jun; 16(6):749-53. PubMed ID: 20453014
[TBL] [Abstract][Full Text] [Related]
36. MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Wattjes MP; Wijburg MT; Vennegoor A; Witte BI; de Vos M; Richert ND; Uitdehaag BM; Barkhof F; Killestein J;
J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):879-84. PubMed ID: 26369555
[TBL] [Abstract][Full Text] [Related]
37. Progressive multifocal leukoencephalopathy after natalizumab monotherapy.
Lindå H; von Heijne A; Major EO; Ryschkewitsch C; Berg J; Olsson T; Martin C
N Engl J Med; 2009 Sep; 361(11):1081-7. PubMed ID: 19741229
[TBL] [Abstract][Full Text] [Related]
38. Case Report: Findings Suggestive of Paraclinical Progressive Multifocal Leukoencephalopathy and Lung Cancer-Derived Brain Metastases in an MS Patient Treated With Fingolimod.
Maass F; von Gottberg P; Franz J; Stadelmann C; Bähr M; Weber MS
Front Neurol; 2021; 12():561158. PubMed ID: 33613428
[TBL] [Abstract][Full Text] [Related]
39. Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report.
Naess H; Glad S; Storstein A; Rinaldo CH; Mørk SJ; Myhr KM; Hirsch H
BMC Neurol; 2010 May; 10():32. PubMed ID: 20482768
[TBL] [Abstract][Full Text] [Related]
40. Imaging manifestations of progressive multifocal leukoencephalopathy.
Shah R; Bag AK; Chapman PR; Curé JK
Clin Radiol; 2010 Jun; 65(6):431-9. PubMed ID: 20451009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
